← Back to Search

Single group for Myelodysplastic Syndrome ((ANSWer) Trial)

N/A
Waitlist Available
Led By Hiroomi Tada, MD, Ph.D.
Research Sponsored by Notable Labs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Summary

This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.

Eligible Conditions
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Leukemia
  • Myeloproliferative Neoplasms
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical response to treatment
Secondary outcome measures
Type of clinical treatment responses
Types of somatic tumor mutations

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single groupExperimental Treatment1 Intervention
Documented hematologic malignancy in need of starting an active anti-cancer therapy. This is a non-interventional study.

Find a Location

Who is running the clinical trial?

Notable LabsLead Sponsor
1 Previous Clinical Trials
165 Total Patients Enrolled
Hiroomi Tada, MD, Ph.D.Principal InvestigatorNotable Labs
~21 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top